1. Jensen LO, Terkelsen CJ, Horváth-Puhó E, et al. Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction. Am Heart J 2015; 170: 70-8.
2.
Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007; 28: 1709-16.
3.
Jaski BE, Cohen JD, Trausch J, et al. Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. Am Heart J 1992; 124: 1427-33.
4.
Windecker S, Hernández-Antolín RA, Stefanini GG, et al. Management of ST-elevation myocardial infarction according to European and American guidelines. EuroIntervention 2014; 10 Suppl T: T23-31.
5.
Lee HJ, Song YB, Hahn JY, et al. Multivessel vs single-vessel revascularization in patients with non-ST-segment elevation acute coronary syndrome and multivessel disease in the drug-eluting stent era. Clin Cardiol 2011; 34: 160-5.
6.
Dangas GD, George JC, Weintraub W, et al. Timing of staged percutaneous coronary intervention in multivessel coronary artery disease. JACC Cardiovasc Interv 2010; 3: 1096-9.
7.
Hannan EL, Samadashvili Z, Walford G, et al. Staged versus one-time complete revascularization with percutaneous coronary intervention for multivessel coronary artery disease patients without ST-elevation myocardial infarction. Circ Cardiovasc Interv 2013; 6: 12-20.
8.
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023; 44: 3720-826.
9.
Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e4-17.
10.
Hsieh MJ, Chen CC, Lee CH, et al. Complete and incomplete revascularization in non-ST segment myocardial infarction with multivessel disease: long-term outcomes of first- and second-generation drug-eluting stents. Heart Vessels 2019; 34: 251-8.
11.
Rathod KS, Koganti S, Jain AK, et al. Complete versus culprit-only lesion intervention in patients with acute coronary syndromes. J Am Coll Cardiol 2018; 72: 1989-99.
12.
Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 2019; 381: 1411-21.
13.
Sardella G, Lucisano L, Garbo R, et al. Single-staged compared with multi-staged PCI in multivessel NSTEMI patients: the SMILE trial. J Am Coll Cardiol 2016; 67: 264-72.
14.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.
15.
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 2018; 72: 2231-64.
16.
Yu X, Li Y, Wang Q, et al. One-time versus staged multivessel intervention in intermediate to very high-risk patients with non-ST-segment elevation acute coronary syndromes. Korean Circ J 2016; 46: 774-83.
17.
Yu XF, Li Y, Wang QC, et al. Staged versus “one-time” multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome. J Geriatr Cardiol 2016; 13: 760-7.
18.
Jensen LO, Thayssen P, Farkas DK, et al. Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease. EuroIntervention 2012; 8: 456-64.
19.
Manari A, Varani E, Guastaroba P, et al. Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: insights from the REAL registry. Catheter Cardiovasc Interv 2014; 84: 912-22.
20.
Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv 2010; 3: 22-31.
21.
Wang C, Lang J, Zhang J, et al. Culprit vessel vs. immediate multivessel vs. out-of-hospital staged intervention for patients with non-ST-segment elevation myocardial infarction and multivessel disease. Front Cardiovasc Med 2022; 9: 1033475.
22.
Lee M, Kim DW, Park MW, et al. Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction. PLoS One 2021; 16: e0258525.
23.
Kim YH, Her AY, Jeong MH, et al. Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents. Atherosclerosis 2020; 301: 54-64.
24.
Kim YH, Her AY, Jeong MH, et al. Outcomes of different reperfusion strategies of multivessel disease undergoing newer-generation drug-eluting stent implantation in patients with non-ST-elevation myocardial infarction and chronic kidney disease. J Clin Med 2021; 10: 4629.
25.
Kim MC, Jeong MH, Ahn Y, et al. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization. Int J Cardiol 2011; 153: 148-53.
26.
Kim MC, Hyun JY, Ahn Y, et al. Optimal revascularization strategy in non-ST-segment-elevation myocardial infarction with multivessel coronary artery disease: culprit-only versus one-stage versus multistage revascularization. J Am Heart Assoc 2020; 9: e016575.
27.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-5.
28.
Chaimani A, Higgins JP, Mavridis D, et al. Graphical tools for network meta-analysis in STATA. PLoS One 2013; 8: e76654.
29.
Gąsior P, Desperak P, Gierlaszyńska K, et al. Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome. Adv Interv Cardiol 2013; 9: 136-45.
30.
Jang JS, Jin HY, Seo JS, et al. Meta-analysis of multivessel versus culprit-only percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome and multivessel coronary disease. Am J Cardiol 2015; 115: 1027-32.
31.
Mariani J, Macchia A, De Abreu M, et al. Multivessel versus single vessel angioplasty in non-ST elevation acute coronary syndromes: a systematic review and metaanalysis. PLoS One 2016; 11: e0148756.
32.
Hassanin A, Brener SJ, Lansky AJ, et al. Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome. EuroIntervention 2015; 11: 293-300.
33.
Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2022; 79: e21-129.
34.
Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407-77.
35.
Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2023; 82: 833-955.
36.
Ando T, Takagi H, Grines CL. Complete versus incomplete revascularization with drug-eluting stents for multi-vessel disease in stable, unstable angina or non-ST-segment elevation myocardial infarction: a meta-analysis. J Interv Cardiol 2017; 30: 309-17.
37.
Gibson CM, Ryan KA, Murphy SA, et al. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol 1999; 34: 974-82.
38.
Nct. Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease. https://clinicaltrialsgov/show/NCT03621501. 2018.
39.
Biscaglia S, Serenelli M, Sole AA, et al. TCT-33 complete versus culprit-only strategy in older patients with MI and multivessel disease: results from a cohort study based on 4 International Registries. J Am Coll Cardiol 2021; 78: B13.
